ELEVATION ONCOLOGY INC shareholders Q3 2023

ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 42 filers reported holding ELEVATION ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

ELEVATION ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,370,142$1,570,4562.08%
Aisling Capital Management LP 2,834,910$1,878,4110.77%
venBio Partners LLC 2,914,255$1,930,9850.55%
TANG CAPITAL MANAGEMENT LLC 4,000,000$2,650,4000.37%
Velan Capital Investment Management LP 497,299$329,5100.27%
SPHERA FUNDS MANAGEMENT LTD. 900,000$596,3400.11%
DAFNA Capital Management LLC 450,000$298,1700.09%
Ikarian Capital, LLC 1,171,939$776,5270.09%
CAXTON CORP 21,813$14,4530.06%
BVF INC/IL 2,312,200$1,532,0640.04%
Orbimed Advisors 1,500,000$993,9000.02%
ARMISTICE CAPITAL, LLC 750,000$496,9500.01%
Annandale Capital, LLC 50,000$330.01%
ExodusPoint Capital Management, LP 999,546$6620.01%
BOOTHBAY FUND MANAGEMENT, LLC 256,715$170,0990.00%
Hudson Bay Capital Management LP 1,092,588$723,9480.00%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 10,999$7,2880.00%
TWO SIGMA INVESTMENTS, LP 438,588$290,6080.00%
MILLENNIUM MANAGEMENT LLC 3,032,214$2,009,1450.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 56,500$37,4370.00%
External links

This page lists ELEVATION ONCOLOGY INC's shareholders in Q3 2023. To view ELEVATION ONCOLOGY INC's shareholder history, click here.